Kong, T., Mabry, A., Highkin, M., Wang, A. Z., Hoog, J., Guo, Z., Gonzales-Gonzales, A., Thomas, S., Song, Y., Gao, F., Opyrchal, M., Peterson, L., Ademuyiwa, F., Margenthaler, J., Aft, R., Glover-Collins, K., Nehring, L., Tao, Y., Sanati, S., Hagemann, I. S., Boulos, F., Holt, M., Ding, L., Zhu, W., Oh, S. T., Wang, J., Witkiewicz, A. K., Knudsen, E. S., Bose, R., Weber, J. D., Goetz, M., Northfelt, D., Luo, J., Ma, C. X. (2026). Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial. Nature Communications. https://doi.org/10.1038/s41467-026-68570-6